About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Mad2l1tm1Sorg
targeted mutation 1, Peter K Sorger
MGI:2178781
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Mad2l1tm1Sorg/Mad2l1tm1Sorg involves: 129S2/SvPas * C57BL/6 MGI:3531554
ht2
Mad2l1tm1Sorg/Mad2l1+ involves: 129S2/SvPas MGI:3620040
ht3
Mad2l1tm1Sorg/Mad2l1+ involves: 129S2/SvPas * C57BL/6 MGI:3531562
cx4
Mad2l1tm1Sorg/Mad2l1+
Usp44tm1.2Pjgl/Usp44tm1.2Pjgl
involves: 129S2/SvPas * 129S4/SvJae * 129S7/SvEvBrd MGI:5478537
cx5
Mad1l1tm1.1Ktj/Mad1l1+
Mad2l1tm1Sorg/Mad2l1+
involves: 129S2/SvPas * BALB/c * C57BL/6J MGI:3698008


Genotype
MGI:3531554
hm1
Allelic
Composition
Mad2l1tm1Sorg/Mad2l1tm1Sorg
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mad2l1tm1Sorg mutation (1 available); any Mad2l1 mutation (14 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygous mutant embryos die in utero between E6.5 and E7.5

cellular
• strikingly, ~25% of mitotic cells contain one or more lagging chromosomes, suggesting that anaphase proceeds in the absence of complete chromosome-microtubule attachment
• in utero, E6.5-E7.5 mutant embryos show a significant reduction in the total number of mitotic cells
• at E5.5, mutant embryonic cells assemble normal spindles and undergo mitosis but are unable to arrest in response to drug-induced spindle disruption, indicating loss of a functional spindle assembly checkpoint
• absence of a functional spindle assembly checkpoint allows mutant cells to proceed even when unattached chromosomes are present, resulting in widespread chromosome missegregation
• in vitro, cell death is restricted to the rapidly dividing cells of the inner cell mass
• mutant embryos undergo programmed cell death after the initiation of gastrulation at E6.5-E7.5; at this stage, wild-type embryos contain only a few apoptotic cells near the embryo center
• in vitro, the ICM of mutant embryos stops proliferating after E6.5
• in contrast, the postmitotic and highly polyploid trophoblast giant cells continue to grow in size through E8.5

embryo
N
• homozygous mutant embryos appear normal both in utero and in culture until E5.5
• in vitro, cell death is restricted to the rapidly dividing cells of the inner cell mass
• mutant embryos undergo programmed cell death after the initiation of gastrulation at E6.5-E7.5; at this stage, wild-type embryos contain only a few apoptotic cells near the embryo center
• in vitro, the ICM of mutant embryos stops proliferating after E6.5
• in contrast, the postmitotic and highly polyploid trophoblast giant cells continue to grow in size through E8.5
• mutant embryos are small relative to wild-type embryos
• mutant embryos appear grossly abnormal relative to wild-type embryos
• virtually no mutant ICM cells persist to E8.5

growth/size/body
• mutant embryos are small relative to wild-type embryos




Genotype
MGI:3620040
ht2
Allelic
Composition
Mad2l1tm1Sorg/Mad2l1+
Genetic
Background
involves: 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mad2l1tm1Sorg mutation (1 available); any Mad2l1 mutation (14 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• chromosomal instability is much higher than in wild-type MEFs
• at 5 months of age 15% of splenocytes are aneuploid; however no early aging related phenotypes are seen in heterozygotes at 19 to 27 months of age and no increase in the number of senescent MEFs is seen compared to wild-type (J:105717)
• 7.2% of MEFs are aneuploid for chromosome 2 compared to 1.4% of wild-type MEFs
• mutant MEFs injected into athymic nude mice produced tumors in 8/8 mice within 4 weeks compared to no tumors from wild-type MEFs; tumors are 40% smaller at 6 weeks compared to than produced by MEFs from Mad1/Mad2 mutants

neoplasm
• mutant MEFs induce tumors in 100% of athymic nude mice in 4 weeks




Genotype
MGI:3531562
ht3
Allelic
Composition
Mad2l1tm1Sorg/Mad2l1+
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mad2l1tm1Sorg mutation (1 available); any Mad2l1 mutation (14 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• at 18-19 months of age, heterozygotes show a high frequency of papillary lung adenocarcinomas relative to age-matched wild-type mice
• in contrast, the background rate of lymphomas detected in ageing heterozygotes remains unchanged relative to wild-type

cellular
N
• initial studies indicated that heterozygotes develop normally, with blastocysts exhibiting no evidence of a defective mitotic checkpoint as assayed by reactivity to phospho-histone 3 antibody; premature sister-chromatid separation was not examined in initial experiments
• MEFs from 4 out of 5 heterozygotes exhibit high frequencies of premature anaphase (sister-chromatid separation) relative to wild-type cultures
• all heterozygous MEF cultures display a significant increase in the number of aneuploid cells relative to wild-type cultures
• the % of aneuploid cells correlates with the severity of premature anaphase, suggesting a direct relationship between the severity of loss of checkpoint control and chromosome mis-segregation

hematopoietic system
• heterozygotes are viable and largely normal but exhibit atypical (increased) germinal center formation in spleen relative to wild-type mice

immune system
• heterozygotes are viable and largely normal but exhibit atypical (increased) germinal center formation in spleen relative to wild-type mice

respiratory system
• at 18-19 months of age, heterozygotes show a high frequency of papillary lung adenocarcinomas relative to age-matched wild-type mice
• in contrast, the background rate of lymphomas detected in ageing heterozygotes remains unchanged relative to wild-type




Genotype
MGI:5478537
cx4
Allelic
Composition
Mad2l1tm1Sorg/Mad2l1+
Usp44tm1.2Pjgl/Usp44tm1.2Pjgl
Genetic
Background
involves: 129S2/SvPas * 129S4/SvJae * 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mad2l1tm1Sorg mutation (1 available); any Mad2l1 mutation (14 available)
Usp44tm1.2Pjgl mutation (0 available); any Usp44 mutation (42 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• chromosome instability is not exacerbated compared with cells form Mad2l1tm1Sorg heterozygotes




Genotype
MGI:3698008
cx5
Allelic
Composition
Mad1l1tm1.1Ktj/Mad1l1+
Mad2l1tm1Sorg/Mad2l1+
Genetic
Background
involves: 129S2/SvPas * BALB/c * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mad1l1tm1.1Ktj mutation (0 available); any Mad1l1 mutation (65 available)
Mad2l1tm1Sorg mutation (1 available); any Mad2l1 mutation (14 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mutant MEFs induce tumors in 100% of athymic nude mice in 4 weeks

cellular
• chromosomal instability is much higher than in wild-type MEFs
• 14.5% of MEFs are aneuploid for chromosome 2 compared to 1.4% of wild-type MEFs
• mutant MEFs injected into athymic nude mice produced tumors in 8/8 mice within 4 weeks compared to no tumors from wild-type MEFs
• stringency of spindle assembly checkpoint (SAC) mediated arrest in response to nocodazole is weaker in mutant MEFs





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory